NATURE’S SUNSHINE PRODUCTS, INC. Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax of $22.82 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest · last filed 2021-03-10
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2019-03-31 was $2.93M, a 80.75% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2018-03-31 was $1.62M.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss), including portion attributable to noncontrolling interest, before tax for fiscal 2020 was $22.82M, a 45.90% increase from fiscal 2019.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss), including portion attributable to noncontrolling interest, before tax for fiscal 2019 was $15.64M, a 388.81% increase from fiscal 2018.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss), including portion attributable to noncontrolling interest, before tax for fiscal 2018 was $3.20M, a 0.68% decline from fiscal 2017.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss), including portion attributable to noncontrolling interest, before tax for fiscal 2017 was $3.22M, a 65.23% decline from fiscal 2016.
| Period end | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 3 month | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 12 month | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 12 month as first filed |
|---|---|---|---|
| 2020-12-31 | $22.82M 10-K · filed 2021-03-10 | ||
| 2019-12-31 | $15.64M 10-K · filed 2021-03-10 | ||
| 2019-03-31 | $2.93M 10-Q · filed 2019-05-09 | ||
| 2018-12-31 | $3.20M 10-K · filed 2020-03-11 | ||
| 2018-03-31 | $1.62M 10-Q · filed 2019-05-09 | ||
| 2017-12-31 | $3.22M 10-K · filed 2019-03-08 | ||
| 2016-12-31 | $9.27M 10-K · filed 2019-03-08 | $0.00 10-K · filed 2017-03-14 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-14 | ||
| 2014-12-31 | -$4.00M 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |